-
-
-
-
-
-
-
TuHURA Biosciences presents cancer immunotherapy research at ASH meeting
-
-
-
-
-
-
-
Brookline Capital Markets Starts TuHURA Biosciences (HURA) at Buy
-
-
-
-
-
-
-
TuHURA Biosciences (HURA) PT Lowered to $12 at H.C. Wainwright
-
-
-
-
-
-
-
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
-
-
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

